Jared Gollob
Chief Medical Officer · 1 filing · Latest: Mar 2, 2026
Kymera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KYMR | Jared Gollob | Chief Medical Officer | Mar 4, 2026 | Sale | $85.30 | 4,895 | $417.5K | 117,134 | |
KYMR | Jared Gollob | Chief Medical Officer | Mar 2, 2026 | Sale | $88.93 | 5,613 | $499.1K | 122,029 | |
KYMR | Gollob Jared | — | Mar 2, 2026 | Proposed Sale | $90.10 | 10,613 | $956.2K | — | |
KYMR | Jared Gollob | — | Dec 8, 2025 | Proposed Sale | $66.62 | 49,307 | $3.3M | — | |
KYMR | Jared Gollob | — | Oct 15, 2025 | Proposed Sale | $58.26 | 59,576 | $3.5M | — | |
KYMR | Jared Gollob | — | Oct 13, 2025 | Proposed Sale | $57.21 | 3,114 | $178.2K | — | |
KYMR | Gollob Jared | — | Mar 3, 2025 | Proposed Sale | $31.35 | 5,740 | $179.9K | — |